Aloe Vera Petrolatum Jelly

Manufacturer
ASTONEA LABS PRIVATE LIMITED
Effective date
2024-06-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:14:20

Label at a glance#

ProductAloe Vera Petrolatum Jelly
Active ingredientPETROLATUM
Label structure11 sections

Indications and uses

temporarily protects minor cuts, scrapes, burns and sunburn temporarily protects and helps relieve chapped or cracked skin helps protect from the drying effects of wind and cold weather helps treat and prevent diaper rash helps seal out wetness

Dosage and administration

apply as needed

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

White Petrolatum (99.35% w/w)

Purpose

OTC - PURPOSE SECTION

Skin protectant

Uses

INDICATIONS & USAGE SECTION

  • temporarily protects minor cuts, scrapes, burns and sunburn
  • temporarily protects and helps relieve chapped or cracked skin
  • helps protect from the drying effects of wind and cold weather
  • helps treat and prevent diaper rash
  • helps seal out wetness

Warnings:

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • do not get into eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens
  • symptoms last for more than 7 days or clean up and occur again in a few days

Do not use on

OTC - DO NOT USE SECTION

  • deep or puncture wounds
  • animal bites
  • serious burns

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • If swallowed, get medical help or contact a Poison Control Center right away

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply as needed

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Aloe vera extract, Vitamin E , Fragrance

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display and Drug Fact PanelPrincipal Display and Drug Fact Panel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2639233petrolatum 99.4 % Topical OintmentPSN2
2639233petrolatum 0.994 MG/MG Topical OintmentSCD2
2639233petrolatum 99.35 % Topical OintmentSY2
2639233petrolatum 99.4 % Topical OintmentSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
77338-103-032026-01-29C16284748780-149896155-c553-586f-e063-e6dba90add90Aloe Vera Petroleum Jelly
77338-103-052026-01-29C16284748780-149896155-c553-586f-e063-e6dba90add90Aloe Vera Petroleum Jelly

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
77338-103-03Aloe Vera Petrolatum Jelly226 g in 1 JARJELLY2262
77338-103-05Aloe Vera Petrolatum Jelly368 g in 1 JARJELLY3682

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
77338-103ALOE VERA PETROLATUM JELLY (PETROLATUM) JELLY [ASTONEA LABS PRIVATE LIMITED]22 package rows20240627_ffe98086-b5c3-4731-e053-6394a90a28dc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
77338-10377338-103-05, 77338-103-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1bbaa2b3-9325-9aab-e063-6394a90a14c9ffe98086-b5c3-4731-e053-6394a90a28dc2024-06-25WarningsExact identifier
spl id: 1bbaa2b3-9325-9aab-e063-6394a90a14c9
spl set id: ffe98086-b5c3-4731-e053-6394a90a28dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.